Brief: NovaBay Partners With Harrow Health's ImprimisRx To Promote Prescription Avenova
July 19 (Reuters) - Harrow Health Inc HROW.O :
* NOVABAY PHARMACEUTICALS PARTNERS WITH HARROW HEALTH’S
IMPRIMISRX® TO PROMOTE PRESCRIPTION AVENOVA
Source text for Eikon: ID:nBw3hkD5za
Further company coverage: HROW.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Stablecoin Development
See all newsBrief: Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
Brief: Tether Says Participated In A $134 Million Financing Round For Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Announces Name Change To Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Says David Lazar Resigns As CEO
Brief: NovaBay Pharmaceuticals Files For Mixed Shelf Of Up To $200 Million - SEC Filing